CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Configurations

Configuration 1 (hide)

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

History

No history.

Information

Published : 2021-05-19 14:15

Updated : 2024-02-28 18:28


NVD link : CVE-2017-17678

Mitre link : CVE-2017-17678

CVE.ORG link : CVE-2017-17678


JSON object : View

Products Affected

bmc

  • remedy_mid-tier
CWE
CWE-79

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')